Back to search results

Mindfulness and Pain Management for Chronic Pain

This study is looking at two approaches to help people with chronic pain who are also taking long-term opioid medications. It's testing if "Mindfulness-Oriented Recovery Enhancement (MORE)" and special "Patient-Centered Chronic Pain Management Visits" can reduce your pain, improve your quality of life, and lower risks linked to opioid use. You might be able to join if you are 18 or older, have had chronic pain for at least three months, and are currently taking opioid therapy for that pain. The study will measure changes in opioid misuse and chronic pain over 12 months to see how well these interventions work.

Study design
This interventional study plans to enroll 300 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06387290

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

Recruiting
PHASE3Ages 18+InterventionalTreatment
University of Utah
~300 participants
Updated 2026-02-03 on ClinicalTrials.gov
What's tested:Mindfulness Oriented Recovery EnhancementPatient-Centered Chronic Pain Management Visits

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Opioid Misuse
Measured over Change from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up)
+1 more outcome measured

Conditions

Chronic Pain
Prescription Opioid Misuse
Substance-Related Disorders
Pain
Narcotic-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Opioid-Related Disorders
Neurologic Manifestations

Explore related trials

Chronic Pain

Where it's being run

3 sites across 3 states
California1
New Jersey1
Utah1

Who to contact

Hannah Pfeffer, MSW
[email protected]
619-500-4668
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 +
Current chronic pain diagnosis (pain for ≥3 months) determined by physician assessment
Prescribed long-term opioid therapy (≥3 months)
Score \>=3 on the Pain Enjoyment General Activity scale
Score \>=9 on the Current Opioid Misuse Measure OR lifetime psychiatric or substance use disorder diagnosis OR benzodiazepine use OR history of overdose OR patient or physician determination that risks of opioid use may outweigh the benefits of opioid use

Exclusion

Chronic pain due to a cancer diagnosis
Active suicidal intent, schizophrenia, psychotic disorder
Prior experience with Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive Therapy, Mindfulness-Based Relapse Prevention, or Mindfulness-Oriented Recovery Enhancement

What this trial measures

  • Opioid MisuseChange from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up)

    Opioid misuse as evidenced by triangulated aggregate of self-reported Current Opioid Misuse Measure and/or interview via Addiction Behaviors Checklist and/or urine screen

  • Chronic PainChange from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up)

    Change in Chronic pain will be measured from baseline through study completion using the Pain, Enjoyment of Life, and General Activity Scale (PEG). Scoring can be determined in one of two ways: 1. A total sum score from 0 to 30, with higher scores indicating more severe pain and pain-related interference with life and activities 2. Dividing the sum of responses to all three items by 3 to get the mean score on a scale of 0-10, with higher scores indicating more severe pain and pain-related interference with life and activities.